Jonathan N. Pruneda
Impact in
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Glycosylation and Glycoproteins Research
- Oncology top 5%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 30
- Protein Degradation and Inhibitors 10
- Glycosylation and Glycoproteins Research 9
- Oncology 13
- Cancer-related Molecular Pathways 7
- PARP inhibition in cancer therapy 4
- Co-authors
- Rachel E. Klevit (10 shared papers)David Komander (13 shared papers)Allan M. Weissman (1 shared paper)Meredith B. Metzger (1 shared paper)Peter S. Brzović (8 shared papers)Kirby N. Swatek (6 shared papers)Christina Gladkova (3 shared papers)Jane L. Wagstaff (3 shared papers)
- Journals
- Molecular Cell (7 papers)The EMBO Journal (7 papers)eLife (4 papers)FEBS Journal (2 papers)Cell Host & Microbe (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Jonathan N. Pruneda
44 papers receiving 2.8k citations
Jonathan N. Pruneda's Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Biology 2.4k
- Oncology 836
- Endocrinology 142
- Parasitology 123
- Cell Biology 303
Countries citing papers authored by Jonathan N. Pruneda
This map shows the geographic impact of Jonathan N. Pruneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan N. Pruneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan N. Pruneda more than expected).
Fields of papers citing papers by Jonathan N. Pruneda
This network shows the impact of papers produced by Jonathan N. Pruneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan N. Pruneda. The network helps show where Jonathan N. Pruneda may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan N. Pruneda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination Hit paper breakdown → | 2013 | 462 |
| 2 | 2012 | 260 | |
| 3 | 2014 | 241 | |
| 4 | 2014 | 183 | |
| 5 | 2019 | 183 | |
| 6 | 2015 | 165 | |
| 7 | 2012 | 162 | |
| 8 | 2013 | 127 | |
| 9 | 2016 | 120 | |
| 10 | 2011 | 119 | |
| 11 | 2016 | 110 | |
| 12 | 2011 | 78 | |
| 13 | 2012 | 72 | |
| 14 | 2014 | 58 | |
| 15 | 2018 | 56 | |
| 16 | 2017 | 49 | |
| 17 | 2018 | 49 | |
| 18 | 2016 | 48 | |
| 19 | 2016 | 44 | |
| 20 | 2020 | 43 |
About Jonathan N. Pruneda
Jonathan N. Pruneda is a scholar working on Molecular Biology, Oncology, Epidemiology, Biotechnology and Parasitology, having authored 48 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (30 papers), Protein Degradation and Inhibitors (10 papers), Glycosylation and Glycoproteins Research (9 papers), Cancer Research and Treatments (8 papers), Autophagy in Disease and Therapy (8 papers), Cancer-related Molecular Pathways (7 papers), Toxoplasma gondii Research Studies (6 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Molecular Biology (2.4k citations), Oncology (836 citations), Endocrinology (142 citations), Parasitology (123 citations) and Cell Biology (303 citations). Jonathan N. Pruneda has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Rachel E. Klevit, David Komander, Allan M. Weissman, Meredith B. Metzger, Peter S. Brzović, Kirby N. Swatek, Christina Gladkova, Jane L. Wagstaff, Stefan M.V. Freund and Martin A. Michel. Their work appears in journals such as Molecular Cell, The EMBO Journal, eLife, FEBS Journal and Cell Host & Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.